Gupta Suneel 4
4 · Protagonist Therapeutics, Inc · Filed Oct 23, 2023
Insider Transaction Report
Form 4
Gupta Suneel
EVP Clinical Operations
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2023-10-19−20,000→ 50,000 totalExercise: $7.38Exp: 2029-01-14→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2023-10-19$7.38/sh+20,000$147,600→ 168,317 total
Footnotes (2)
- [F1]Includes an aggregate of 280 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2023.
- [F2]These stock options are fully vested.